Literature DB >> 21234714

Significance of microsatellite instability (MSI) for colorectal cancer following adjuvant therapy with doxifluridine.

Toshiaki Watanabe, Keiji Matsuda, Soichiro Ishihara, Keijiro Nozawa, Tamuro Hayama, Hideki Yamada, Hisae Iinuma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21234714     DOI： 10.1007/s12032-010-9799-2

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  3 in total

1.  Molecular predictors of survival after adjuvant chemotherapy for colon cancer.

Authors:  T Watanabe; T T Wu; P J Catalano; T Ueki; R Satriano; D G Haller; A B Benson; S R Hamilton
Journal:  N Engl J Med       Date:  2001-04-19       Impact factor: 91.245

2.  Clinical significance of microsatellite instability for stage II or III colorectal cancer following adjuvant therapy with doxifluridine.

Authors:  Byung Woog Kang; Jong Gwang Kim; Soo Jung Lee; Yee Soo Chae; Joon Ho Moon; Sang Kyun Sohn; Seong Woo Jeon; Min Kyu Jung; Kyoung-Hoon Lim; You Seok Jang; Jun Seok Park; Soo Han Jun; Gyu-Seog Choi
Journal:  Med Oncol       Date:  2010-10-16       Impact factor: 3.064

3.  Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

Authors:  Christine M Ribic; Daniel J Sargent; Malcolm J Moore; Stephen N Thibodeau; Amy J French; Richard M Goldberg; Stanley R Hamilton; Pierre Laurent-Puig; Robert Gryfe; Lois E Shepherd; Dongsheng Tu; Mark Redston; Steven Gallinger
Journal:  N Engl J Med       Date:  2003-07-17       Impact factor: 91.245
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.